UTICA, N.Y.--(BUSINESS WIRE)--Sep. 24, 2015-- CONMED Corporation (NASDAQ:CNMD) today announced that it has appointed Nathan “Nate” Folkert as Vice President and General Manager of its Orthopedics business.

Mr. Folkert brings 15 years of diverse medical device experience to CONMED. Most recently, he served as President of Zimmer’s Trauma Division, where he held full P&L responsibility and oversaw sales, marketing, global research and development, manufacturing, regulatory, quality and human resources. Prior to that, he was General Manager of Zimmer’s Canadian operations, where he was responsible for all major orthopedic product segments and delivered above-market growth while improving operating profitability. He previously served as Director of Marketing of Zimmer’s U.S. Knee business. Mr. Folkert started his career at Stryker Medical in 2000, where he held several managerial positions beginning in manufacturing operations, subsequently moving into product management and group marketing.

Curt R. Hartman, CONMED’s President and Chief Executive Officer, commented, “We are very excited to welcome Nate to CONMED and our executive team. His leadership abilities coupled with a track record of delivering exceptional results across many assignments, covering both procedure-specific products and capital equipment, will further accelerate our efforts to enhance innovation and profitably expand our market share in our Orthopedics business.”

Mr. Folkert added, “I am excited to join CONMED’s executive team and lead the Orthopedics business. The portfolio of products represents a tremendous value proposition for our customers, and I look forward to leading this talented team and leveraging CONMED’s platform of innovative, leading technologies.”

Mr. Folkert earned an MBA from Notre Dame’s Mendoza College of Business and a BS in Political Science from the U.S. Military Academy at West Point.

About CONMED Corporation

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. The Company distributes its products worldwide from several manufacturing locations. CONMED has a direct selling presence in 16 countries outside the United States, and international sales constitute over 50% of the Company’s total sales. Headquartered in Utica, New York, the Company employs 3,400 people. For more information, visit www.conmed.com.

Forward Looking Information

This press release contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company's performance on a going-forward basis. The forward-looking statements in this press release involve risks and uncertainties which could cause actual results, performance or trends, to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. In addition to general industry and economic conditions, factors that could cause actual results to differ materially from those discussed in the forward-looking statements in this press release include, but are not limited to the risks relating to forward-looking statements discussed in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2014.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150924006020/en/

Source: CONMED Corporation

CONMED Corporation
Luke Pomilio, 315-624-3202
Chief Financial Officer